viernes, 9 de mayo de 2025

FDA Approves Novel Treatment for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer Sharon Worcester, MA May 08, 2025

https://www.medscape.com/viewarticle/fda-approves-novel-treatment-kras-mutated-recurrent-low-2025a1000b8o

No hay comentarios:

Publicar un comentario